These immunosuppressive populations exerted their inhibitory effects through the secretion of potent immunosuppressive cytokines, including transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10), thereby creating an immunologically privileged niche for tumor progression [8,9]. This evidence concerns the gene TGFB1 and neoplasm.